MMR and CMR in Chronic Phase Chronic Myeloid Leukemia Patients: Role of Sokal Score and Different Tyrosine Kinase Inhibitors On Time of Their Obtention, Maintenance and Failure-Free Survival
Mauricette Michallet(Université Claude Bernard Lyon 1), Franck E. Nicolini(Université Claude Bernard Lyon 1), Madeleine Etienne(Hôpital Lyon Sud), Stéphane Morisset(Lyon 1 Université), Fiorenza Barraco(Hôpital Lyon Sud), Xavier Thomas(Hôpital Lyon Sud), Isabelle Tigaud(Inserm), Oriane Le Borgne(Hôpital Lyon Sud), Mohamad Sobh(Ottawa Hospital), Sandrine Hayette(Hôpital Claude Huriez), Sophie Ducastelle(Hôpital Lyon Sud), Hélène Labussière‐Wallet, Marie Y. Detrait(Hôpital Civil de Charleroi)
Cited by 0
Related Papers
Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study
|The Lancet|2012|1k
Should Adolescents With Acute Lymphoblastic Leukemia Be Treated as Old Children or Young Adults? Comparison of the French FRALLE-93 and LALA-94 Trials
|Journal of Clinical Oncology|2003|606
Pediatric-Inspired Therapy in Adults With Philadelphia Chromosome–Negative Acute Lymphoblastic Leukemia: The GRAALL-2003 Study
|Journal of Clinical Oncology|2009|562
Outcome of Treatment in Adults With Acute Lymphoblastic Leukemia: Analysis of the LALA-94 Trial
|Journal of Clinical Oncology|2004|547